4564.T
OncoTherapy Science,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 22.00
+4.76%Margins
Gross margin
3.6%
EBITDA margin
—
EBIT margin
-101.1%
Net margin
-112.4%
FCF margin
-104.0%
-41.2%
Return on equity
-35.5%
Return on assets
-37.1%
Return on invested capital
0.36x
Asset turnover
-JPY 815.0M
Cash from operations
JPY 5.80
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026